Pentagon issues new guidance for testosterone testing after rescinding previous one
The Pentagon on Thursday issued revised guidance that mandates testosterone deficiency screening for male active-duty and reserve service members older than 30. The department said the new instruction restores screening requirements after an earlier guidance issued this month was temporarily rescinded and aims to create consistent screening and treatment processes across the Defense Health Agency.
Why It Matters
Uniform screening and treatment protocols across the Defense Health Agency affect care access and clinical consistency for thousands of service members; reinstating mandatory testing reverses a brief pause that could have left providers without departmental direction. The move signals the Pentagon is prioritizing a standardized approach to male testosterone deficiency within military health services.
Key Facts
- Issuing body: U.S. Department of Defense (Pentagon)
- When issued: Late Thursday (this month)
- Who is affected: Male active-duty and reserve service members over age 30
- What it requires: Mandatory testosterone deficiency screening
- Purpose stated: To address male testosterone deficiency and establish uniform screening and treatment pathways across the Defense Health Agency (DHA)
The Pentagon released updated guidance late Thursday directing mandatory screening for testosterone deficiency among male active-duty and reserve members older than 30. The department framed the change as a step to address male testosterone deficiency within the force and to standardize how such cases are identified and managed.
This guidance follows an earlier instruction issued earlier in the month that the department temporarily rescinded. Officials indicated the new document is intended to replace the withdrawn guidance and to provide clear, consistent protocols for providers across the Defense Health Agency.
Under the updated guidance, the Defense Health Agency will implement uniform screening and treatment pathways for male service members who meet the age threshold. The Pentagon characterized the policy as an effort to ensure consistent clinical practice and follow-up care across military health facilities.
The directive applies to both active-duty and reserve personnel who are male and older than 30, making testing mandatory rather than optional for that group. The department did not, in the information provided here, publish detailed clinical criteria, testing schedules, or treatment specifics in this announcement.
Pentagon officials have not released additional operational details in this summary, including timelines for implementation or how the policy change will be communicated to individual service members and treating clinicians.
Keep Reading
Trump ‘confident’ Republicans will pass next farm bill vote
US will allow ‘core’ Iranian delegation join United Nations summit in New York
Trump administration gets green light to proceed with homelessness program overhaul
